Cargando…
The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution
PURPOSE: Desmoid fibromatosis (DF) is an aggressive fibroblastic neoplasm with a high propensity for local recurrence. Although multiple therapeutic modalities seem effective for DF, the standard systemic treatment for symptomatic and progressive DF remains controversial. As targeted therapy, tyrosi...
Autores principales: | Zheng, Chuanxi, Zhou, Yong, Wang, Yitian, Luo, Yi, Tu, Chongqi, Min, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524188/ https://www.ncbi.nlm.nih.gov/pubmed/33061299 http://dx.doi.org/10.2147/DDDT.S271008 |
Ejemplares similares
-
Desmoid-Type Fibromatosis
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2020) -
The efficacy and safety of apatinib in Ewing’s sarcoma: a retrospective analysis in one institution
por: Wang, Yitian, et al.
Publicado: (2018) -
Desmoid Fibromatosis of Submandibular Region
por: Ali, Rohana, et al.
Publicado: (2014) -
Desmoid fibromatosis of the chest wall
por: Ong, QiHao, et al.
Publicado: (2018) -
Desmoid tumor (fibromatosis) of the head and neck
por: Barnouti, Hazim N.
Publicado: (2015)